Clinical relevance of transforming growth factor α, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors

Hepatology

Volumn 28, Issue 4 I, 1998, Pages 971-979

  De Jong, Koert P ^a   Slellema, Rudi ^a   Karrenbeld, Arend ^a   Koudstaal, Jan ^a   Gouw, Annette S H ^a   Sluiter, Wlm J ^a   Peeters, Paul M J G ^a   Slooff, Maarten J H ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE; PRIORITY JOURNAL; RISK FACTOR;

ADENOCARCINOMA; ADULT; AGED; CELL DIVISION; CELL NUCLEUS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031708626     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280411     Document Type: Article

References (23)

1. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71:4252-4266.
2. August DA, Ottow RT, Sugarbaker PH. Clinical perspective of human colorectal cancer metastasis. Cancer Metastas Rev 1984;3:303-324.
3. Hughes KS, Simon R, Songhorabodi S, Adson MA, IIstrup DM, Former JG, Maclean BJ, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of hepatic metastases. Surgery 1988;103:278-288.
4. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
5. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-946.
6. de Jong KP, Slooff MJH, de Vries EGE, Brouwers MAM, Terpstra OT. Effect of partial liver resection on tumour growth. J Hepatol 1996;25:109-121.
7. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, Fidler IJ. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res 1988;48:1943-1948.
8. Nicolson GL. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp Cell Res 1993;204:171-180.
9. Jass JR, Sobin LH. Histological typing of intestinal tumours. International histological classification of tumours. Berlin: Springer Verlag, 1989:32-33.
10. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Am J Pathol 1996;148:1531-1541.
11. Fausto N, Mead JE, Braun L, Thompson NL, Panzica M, Goyette M, Bell GI, et al. Proto-oncogene expression and growth factors during liver regeneration. Symp Fundam Cancer Res 1986;39:69-86.
12. Michalopoulos G. Liver regeneration and growth factors: old puzzles and new perspectives. Lab Invest 1992;67:413-415.
13. Selden AC, Hodgson HJ. Growth factors and the liver. Gut 1991;32:601-603.
14. Olsen PS, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexo E. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. HEPATOLOGY 1988;8:992-996.
15. Rasmussen TN, Jorgensen PE, Almdal T, Kirkegaard P, Olsen PS. Stimulatory effect of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Scand J Gastroenterol 1992;27:372-374.
16. Webber EM, FitzGerald MJ, Brown PI, Bartlett MH, Fausto N. Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. HEPATOLOGY 1993;18:1422-1431.
17. Vesey DA, Selden AC, Woodman AC, Hodgson HJE Effect of in vivo administration of an antibody to epidermal growth factor on the rapid increase in DNA synthesis induced by partial hepatectomy in the rat. Gut 1992;33:831-835.
18. Russell WE, Dempsey PJ, Sitaric S, Peck AJ, Coffey RJ. Transforming growth factor-alpha (TGF alpha) concentrations increase in regenerating rat liver: evidence for a delayed accumulation of mature TGF alpha. Endocrinology 1993;133:1731-1738.
19. Tomiya T, Fujiwara K. Serum levels of transforming growth factor-alpha in patients after partial hepatectomy as determined with an enzymelinked immunosorbent assay. HEPATOLOGY 1993;18:304-308.
20. Ziober BL, Willson JK, Hymphrey LE, Childress-Fields K, Brattain MG. Autocrine transforming growth factor-alpha is associated with progression of transformed properties in human colon cancer cells. J Biol Chem 1993:268:691-698.
21. Huang S, Trujillo JM, Chakrabarty S. Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor alpha. Int J Cancer 1992;52:978-986.
22. Khazaie K, Schirrmacher V, Lichtner RB. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 1993:12:255-274.
23. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, Fidler IJ. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995;1:19-31.